US Stock MarketDetailed Quotes

VIVE Viveve Medical

Watchlist
  • 0.000400
  • +0.000300+300.00%
15min DelayClose Nov 22 16:00 ET
4.29KMarket Cap0.00P/E (TTM)

Viveve Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Total revenue
4.21%1.68M
8.52%1.8M
13.17%1.64M
17.28%6.43M
-12.38%1.71M
6.04%1.62M
134.94%1.65M
11.20%1.45M
-16.57%5.48M
34.18%1.95M
Operating revenue
4.21%1.68M
8.52%1.8M
13.17%1.64M
17.28%6.43M
-12.38%1.71M
6.04%1.62M
134.94%1.65M
11.20%1.45M
-16.57%5.48M
34.18%1.95M
Cost of revenue
-24.23%1.14M
0.81%1.5M
23.69%1.32M
12.02%5.81M
2.76%1.75M
17.07%1.5M
39.03%1.49M
-5.40%1.07M
-6.63%5.18M
8.28%1.7M
Gross profit
378.95%546K
78.18%294K
-16.23%320K
109.46%620K
-116.60%-41K
-52.70%114K
144.96%165K
118.29%382K
-70.87%296K
307.56%247K
Operating expense
-7.10%5.21M
3.99%5.31M
5.12%5.79M
18.00%22.17M
30.11%5.95M
53.80%5.61M
11.72%5.11M
-8.18%5.51M
-39.29%18.79M
-34.09%4.57M
Selling and administrative expenses
17.07%3.41M
15.80%3.39M
2.01%3.65M
-8.47%12.51M
-3.29%3.09M
5.43%2.91M
-12.54%2.93M
-17.96%3.58M
-38.89%13.67M
-38.36%3.19M
Research and development costs
-33.21%1.8M
-11.88%1.92M
10.88%2.14M
88.59%9.67M
107.32%2.86M
204.86%2.7M
78.10%2.18M
17.90%1.93M
-40.34%5.13M
-21.55%1.38M
Operating profit
15.11%-4.66M
-1.52%-5.02M
-6.71%-5.47M
-16.53%-21.55M
-38.49%-5.99M
-61.34%-5.49M
-0.08%-4.95M
11.98%-5.13M
38.22%-18.5M
38.71%-4.32M
Net non-operating interest income expense
-14.51%-292K
-15.92%-284K
-15.38%-270K
-9.89%-1M
-9.92%-266K
-8.51%-255K
-9.87%-245K
-11.43%-234K
79.10%-910K
71.02%-242K
Non-operating interest expense
14.51%292K
15.92%284K
15.38%270K
9.89%1M
9.92%266K
8.51%255K
9.87%245K
11.43%234K
-79.10%910K
-71.02%242K
Other net income (expense)
71.79%-22K
-103.28%-40K
94.03%-21K
136.77%782K
94.62%-7K
-90.24%-78K
165.36%1.22M
-286.81%-352K
72.04%-2.13M
98.07%-130K
Gain on sale of security
----
----
----
79.71%-373K
--0
----
95.32%-86K
---287K
---1.84M
--0
Special income (charges)
--0
--0
----
--1.36M
--0
--0
--1.36M
----
--0
--0
-Less:Other special charges
----
----
----
---1.36M
--0
----
---1.36M
----
----
----
Other non- operating income (expenses)
71.79%-22K
24.53%-40K
67.69%-21K
29.76%-203K
94.62%-7K
-90.24%-78K
-96.30%-53K
28.57%-65K
-79.50%-289K
-364.29%-130K
Income before tax
14.58%-4.98M
-34.58%-5.34M
-0.86%-5.76M
-1.11%-21.77M
-33.33%-6.26M
-58.29%-5.83M
43.51%-3.97M
6.74%-5.72M
48.61%-21.53M
67.89%-4.7M
Income tax
Earnings from equity interest net of tax
--0
-475.95%-455K
-60.53%-122K
33.16%-256K
-13.33%-68K
40.00%-33K
8.14%-79K
58.24%-76K
38.92%-383K
69.39%-60K
Net income
15.06%-4.98M
-43.19%-5.8M
-1.64%-5.89M
-0.51%-22.03M
-33.08%-6.33M
-56.84%-5.86M
43.08%-4.05M
8.23%-5.79M
48.47%-21.92M
67.91%-4.76M
Net income continuous Operations
15.06%-4.98M
-43.19%-5.8M
-1.64%-5.89M
-0.51%-22.03M
-33.08%-6.33M
-56.84%-5.86M
43.08%-4.05M
8.23%-5.79M
48.47%-21.92M
67.91%-4.76M
Minority interest income
Net income attributable to the parent company
15.06%-4.98M
-43.19%-5.8M
-1.64%-5.89M
-0.51%-22.03M
-33.08%-6.33M
-56.84%-5.86M
43.08%-4.05M
8.23%-5.79M
48.47%-21.92M
67.91%-4.76M
Preferred stock dividends
13.19%1.35M
16.62%1.31M
13.14%1.27M
13.06%4.69M
13.18%1.23M
13.01%1.19M
9.60%1.12M
13.14%1.12M
991.84%4.15M
1.09M
Other preferred stock dividends
Net income attributable to common stockholders
10.29%-6.32M
-37.43%-7.1M
-3.50%-7.15M
-2.51%-26.72M
-29.38%-7.56M
-47.20%-7.05M
36.47%-5.17M
5.33%-6.91M
39.25%-26.06M
61.57%-5.84M
Basic earnings per share
11.94%-0.59
-36.73%-0.67
16.25%-0.67
84.00%-2.65
61.08%-0.72
74.72%-0.67
91.46%-0.49
90.21%-0.8
95.18%-16.56
91.39%-1.85
Diluted earnings per share
11.94%-0.59
-36.73%-0.67
16.25%-0.67
84.00%-2.65
61.08%-0.72
74.72%-0.67
91.46%-0.49
90.21%-0.8
95.18%-16.56
91.39%-1.85
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Total revenue 4.21%1.68M8.52%1.8M13.17%1.64M17.28%6.43M-12.38%1.71M6.04%1.62M134.94%1.65M11.20%1.45M-16.57%5.48M34.18%1.95M
Operating revenue 4.21%1.68M8.52%1.8M13.17%1.64M17.28%6.43M-12.38%1.71M6.04%1.62M134.94%1.65M11.20%1.45M-16.57%5.48M34.18%1.95M
Cost of revenue -24.23%1.14M0.81%1.5M23.69%1.32M12.02%5.81M2.76%1.75M17.07%1.5M39.03%1.49M-5.40%1.07M-6.63%5.18M8.28%1.7M
Gross profit 378.95%546K78.18%294K-16.23%320K109.46%620K-116.60%-41K-52.70%114K144.96%165K118.29%382K-70.87%296K307.56%247K
Operating expense -7.10%5.21M3.99%5.31M5.12%5.79M18.00%22.17M30.11%5.95M53.80%5.61M11.72%5.11M-8.18%5.51M-39.29%18.79M-34.09%4.57M
Selling and administrative expenses 17.07%3.41M15.80%3.39M2.01%3.65M-8.47%12.51M-3.29%3.09M5.43%2.91M-12.54%2.93M-17.96%3.58M-38.89%13.67M-38.36%3.19M
Research and development costs -33.21%1.8M-11.88%1.92M10.88%2.14M88.59%9.67M107.32%2.86M204.86%2.7M78.10%2.18M17.90%1.93M-40.34%5.13M-21.55%1.38M
Operating profit 15.11%-4.66M-1.52%-5.02M-6.71%-5.47M-16.53%-21.55M-38.49%-5.99M-61.34%-5.49M-0.08%-4.95M11.98%-5.13M38.22%-18.5M38.71%-4.32M
Net non-operating interest income expense -14.51%-292K-15.92%-284K-15.38%-270K-9.89%-1M-9.92%-266K-8.51%-255K-9.87%-245K-11.43%-234K79.10%-910K71.02%-242K
Non-operating interest expense 14.51%292K15.92%284K15.38%270K9.89%1M9.92%266K8.51%255K9.87%245K11.43%234K-79.10%910K-71.02%242K
Other net income (expense) 71.79%-22K-103.28%-40K94.03%-21K136.77%782K94.62%-7K-90.24%-78K165.36%1.22M-286.81%-352K72.04%-2.13M98.07%-130K
Gain on sale of security ------------79.71%-373K--0----95.32%-86K---287K---1.84M--0
Special income (charges) --0--0------1.36M--0--0--1.36M------0--0
-Less:Other special charges ---------------1.36M--0-------1.36M------------
Other non- operating income (expenses) 71.79%-22K24.53%-40K67.69%-21K29.76%-203K94.62%-7K-90.24%-78K-96.30%-53K28.57%-65K-79.50%-289K-364.29%-130K
Income before tax 14.58%-4.98M-34.58%-5.34M-0.86%-5.76M-1.11%-21.77M-33.33%-6.26M-58.29%-5.83M43.51%-3.97M6.74%-5.72M48.61%-21.53M67.89%-4.7M
Income tax
Earnings from equity interest net of tax --0-475.95%-455K-60.53%-122K33.16%-256K-13.33%-68K40.00%-33K8.14%-79K58.24%-76K38.92%-383K69.39%-60K
Net income 15.06%-4.98M-43.19%-5.8M-1.64%-5.89M-0.51%-22.03M-33.08%-6.33M-56.84%-5.86M43.08%-4.05M8.23%-5.79M48.47%-21.92M67.91%-4.76M
Net income continuous Operations 15.06%-4.98M-43.19%-5.8M-1.64%-5.89M-0.51%-22.03M-33.08%-6.33M-56.84%-5.86M43.08%-4.05M8.23%-5.79M48.47%-21.92M67.91%-4.76M
Minority interest income
Net income attributable to the parent company 15.06%-4.98M-43.19%-5.8M-1.64%-5.89M-0.51%-22.03M-33.08%-6.33M-56.84%-5.86M43.08%-4.05M8.23%-5.79M48.47%-21.92M67.91%-4.76M
Preferred stock dividends 13.19%1.35M16.62%1.31M13.14%1.27M13.06%4.69M13.18%1.23M13.01%1.19M9.60%1.12M13.14%1.12M991.84%4.15M1.09M
Other preferred stock dividends
Net income attributable to common stockholders 10.29%-6.32M-37.43%-7.1M-3.50%-7.15M-2.51%-26.72M-29.38%-7.56M-47.20%-7.05M36.47%-5.17M5.33%-6.91M39.25%-26.06M61.57%-5.84M
Basic earnings per share 11.94%-0.59-36.73%-0.6716.25%-0.6784.00%-2.6561.08%-0.7274.72%-0.6791.46%-0.4990.21%-0.895.18%-16.5691.39%-1.85
Diluted earnings per share 11.94%-0.59-36.73%-0.6716.25%-0.6784.00%-2.6561.08%-0.7274.72%-0.6791.46%-0.4990.21%-0.895.18%-16.5691.39%-1.85
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.25%